Literature DB >> 8114858

The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome)

C T Basson1, G S Cowley, S D Solomon, B Weissman, A K Poznanski, T A Traill, J G Seidman, C E Seidman.   

Abstract

BACKGROUND: The Holt-Oram syndrome is an autosomal dominant condition characterized by skeletal abnormalities that are frequently accompanied by congenital cardiac defects. The cause of these disparate clinical features is unknown. To identify the chromosomal location of the Holt-Oram syndrome gene, we performed clinical and genetic studies.
METHODS: Two large families with the Holt-Oram syndrome were evaluated by radiography of the hands, electrocardiography, and transthoracic echocardiography. Genetic-linkage analyses were performed with polymorphic DNA loci dispersed throughout the genome to identify a locus that was inherited with the Holt-Oram syndrome in family members.
RESULTS: A total of 19 members of Family A had Holt-Oram syndrome with mild-to-moderate skeletal deformities, including triphalangeal thumbs and carpal-bone dysmorphism. All affected members of Family A had moderate-to-severe congenital cardiac abnormalities, such as ventricular or atrial septal defects or atrioventricular-canal defects. Eighteen members of a second kindred (Family B) had Holt-Oram syndrome with moderate-to-severe skeletal deformities, including phocomelia. Twelve of the affected members had no cardiac defects; six had only atrial septal defects. Genetic analyses demonstrated linkage of the disease in each family to polymorphic loci on the long arm of chromosome 12 (combined multipoint lod score, 16.8). These data suggest odds greater than 10(16):1 that the genetic defect for Holt-Oram syndrome is present on the long arm of chromosome 12 (12q2).
CONCLUSIONS: Mutations in a gene on chromosome 12q2 can produce a wide range of disease phenotypes characteristic of the Holt-Oram syndrome. This gene has an important role in both skeletal and cardiac development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8114858     DOI: 10.1056/NEJM199403313301302

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  82 in total

1.  The spectrum of mutations in TBX3: Genotype/Phenotype relationship in ulnar-mammary syndrome.

Authors:  M Bamshad; T Le; W S Watkins; M E Dixon; B E Kramer; A D Roeder; J C Carey; S Root; A Schinzel; L Van Maldergem; R J Gardner; R C Lin; C E Seidman; J G Seidman; R Wallerstein; E Moran; R Sutphen; C E Campbell; L B Jorde
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

2.  TBX5 drives Scn5a expression to regulate cardiac conduction system function.

Authors:  David E Arnolds; Fang Liu; John P Fahrenbach; Gene H Kim; Kurt J Schillinger; Scott Smemo; Elizabeth M McNally; Marcelo A Nobrega; Vickas V Patel; Ivan P Moskowitz
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

3.  Fracture of the proximal pole of the bipartite carpal scaphoid: a probable Holt-Oram-like syndrome.

Authors:  B Saccomanni
Journal:  Hand (N Y)       Date:  2008-10-24

4.  An interspecies heart-to-heart: Using Xenopus to uncover the genetic basis of congenital heart disease.

Authors:  Alexandra MacColl Garfinkel; Mustafa K Khokha
Journal:  Curr Pathobiol Rep       Date:  2017-05-06

Review 5.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

6.  Several common variants modulate heart rate, PR interval and QRS duration.

Authors:  Hilma Holm; Daniel F Gudbjartsson; David O Arnar; Gudmar Thorleifsson; Gudmundur Thorgeirsson; Hrafnhildur Stefansdottir; Sigurjon A Gudjonsson; Aslaug Jonasdottir; Ellisiv B Mathiesen; Inger Njølstad; Audhild Nyrnes; Tom Wilsgaard; Erin M Hald; Kristian Hveem; Camilla Stoltenberg; Maja-Lisa Løchen; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

Review 7.  Probing human cardiovascular congenital disease using transgenic mouse models.

Authors:  Paige Snider; Simon J Conway
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

8.  Atrial Fibrillation and Other Clinical Manifestations of Altered TBX5 Dosage in Typical Holt-Oram Syndrome.

Authors:  Deborah A McDermott; Cathy J Hatcher; Craig T Basson
Journal:  Circ Res       Date:  2008-09-26       Impact factor: 17.367

9.  Evolutionarily conserved Tbx5-Wnt2/2b pathway orchestrates cardiopulmonary development.

Authors:  Jeffrey D Steimle; Scott A Rankin; Christopher E Slagle; Jenna Bekeny; Ariel B Rydeen; Sunny Sun-Kin Chan; Junghun Kweon; Xinan H Yang; Kohta Ikegami; Rangarajan D Nadadur; Megan Rowton; Andrew D Hoffmann; Sonja Lazarevic; William Thomas; Erin A T Boyle Anderson; Marko E Horb; Luis Luna-Zurita; Robert K Ho; Michael Kyba; Bjarke Jensen; Aaron M Zorn; Frank L Conlon; Ivan P Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-23       Impact factor: 11.205

10.  Right into the heart of microRNA-133a.

Authors:  Benjamin Meder; Hugo A Katus; Wolfgang Rottbauer
Journal:  Genes Dev       Date:  2008-12-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.